Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Accounts Payables (2023 - 2025)

Bioharvest Sciences has reported Accounts Payables over the past 3 years, most recently at $2.6 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 25.48% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, down 25.48%, while the annual FY2025 figure was $2.6 million, 25.48% down from the prior year.
  • Accounts Payables was $2.6 million for Q4 2025 at Bioharvest Sciences, down from $3.5 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $4.4 million in Q3 2024 and bottomed at $1.8 million in Q4 2023.
  • The 3-year median for Accounts Payables is $3.5 million (2024), against an average of $3.4 million.
  • Year-over-year, Accounts Payables soared 98.26% in 2024 and then fell 25.48% in 2025.
  • Over 3 years, Accounts Payables stood at $1.8 million in 2023, then soared by 98.26% to $3.5 million in 2024, then dropped by 25.48% to $2.6 million in 2025.
  • The last three reported values for Accounts Payables were $2.6 million (Q4 2025), $3.5 million (Q3 2025), and $3.4 million (Q2 2025) per Business Quant data.